Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900241263164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Toni Fera und 10 weiteren Autor:innen. Beteiligte Einrichtung: Project Consultant, Greater Pittsburgh Area, PA, USA. Hauptthemen laut MEDLINE: Factor Xa Inhibitors, Recombinant Proteins, Factor Xa. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alexion, AstraZeneca Rare Disease.
Abstract (Originalsprache)
Medication-use evaluations are meant to ensure that medication-use processes are consistent with prevailing standards of care, assure optimal use of therapy, and reduce the risk of medication-related problems. Reversal agents for direct oral anticoagulants are a worthy focus for medication-use evaluations for reasons of efficacy, safety, and cost. A multidisciplinary team of experts developed 2 medication-use evaluation templates illustrating the application of professional society guidelines to the appropriate use of andexanet alfa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Project Consultant, Greater Pittsburgh Area, PA, USA.
- Inpatient Antithrombosis Stewardship Service, University of New Mexico Hospital, Albuquerque, NM, USA.
- Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA.
- Mass General Brigham, Boston, MA, USA.
- ASHP Research and Education Foundation, Bethesda, MD, USA.
- Department of Emergency Medicine, University of Mississippi, Jackson, MS, USA.
ORCID-Profile: Charles J Turck
Förderung
- Alexion, AstraZeneca Rare Disease
Zitieren
APA
Fera, T., Burnett, A., Grandoni, J., Moore, M. R., Nussbaum, B. B., Pollack, C. V., Rose, A. E., Spinler, S. A., Streiff, M. B., Turck, C. J., & Fanikos, J. (2025). Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241263164
Vancouver
Fera T, Burnett A, Grandoni J, Moore MR, Nussbaum BB, Pollack CV, et al. Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900241263164
BibTeX
@article{Fera2025,
author = {Fera, Toni and Burnett, Allison and Grandoni, Jessica and Moore, Mary R and Nussbaum, Barbara B and Pollack, Charles V and Rose, Anne E and Spinler, Sarah A and Streiff, Michael B and Turck, Charles J and Fanikos, John},
title = {Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900241263164}
}
EUVIMED